Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
308.58
110.70
20.98
Other Operating Income
0.00
0.00
0.00
Total Operating income
308.58
110.70
20.98
Raw Material Cost
62.24
0.00
15.74
Purchase of Finished goods
83.49
95.28
0.08
(Increase) / Decrease In Stocks
-3.16
-3.69
0.64
Employee Cost
15.09
2.58
0.38
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
53.02
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
54.81
13.21
2.29
Total Expenditure (Excl Depreciation)
265.49
107.38
19.12
Operating Profit (PBDIT) excl Other Income
43.09
3.32
1.86
Other Income
12.31
1.49
0.50
Operating Profit (PBDIT)
55.40
4.81
2.36
Interest
5.83
0.47
0.07
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
49.57
4.34
2.29
Depreciation
2.98
1.63
0.18
Profit Before Tax
46.58
2.71
2.11
Tax
15.34
1.01
0.27
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
31.24
1.69
1.84
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
31.24
1.69
1.84
Share in Profit of Associates
-0.22
-0.49
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.02
1.21
1.84
Equity Capital
65.45
53.50
53.50
Face Value
1.0
10.0
10.0
Reserves
292.03
243.50
26.75
Earnings per share (EPS)
0.47
0.02
0.34
Diluted Earnings per share
0.45
0.02
1.65
Operating Profit Margin (Excl OI)
13.96%
3.0%
8.87%
Gross Profit Margin
16.06%
3.92%
10.92%
PAT Margin
10.12%
1.53%
8.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 178.75% vs 427.65% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 2,463.64% vs -34.24% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 1,197.89% vs 78.49% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 1,140.43% vs 571.43% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Fischer Medical With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
308.58
4,223.79
-3,915.21
-92.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
308.58
4,223.79
-3,915.21
-92.69%
Raw Material Cost
62.24
2,550.79
-2,488.55
-97.56%
Purchase of Finished goods
83.49
0.00
83.49
(Increase) / Decrease In Stocks
-3.16
122.70
-125.86
-102.58%
Employee Cost
15.09
264.93
-249.84
-94.30%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
53.02
0.00
53.02
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
54.81
1,087.46
-1,032.65
-94.96%
Total Expenditure (Excl Depreciation)
265.49
4,025.88
-3,760.39
-93.41%
Operating Profit (PBDIT) excl Other Income
43.09
197.91
-154.82
-78.23%
Other Income
12.31
28.14
-15.83
-56.25%
Operating Profit (PBDIT)
55.40
226.05
-170.65
-75.49%
Interest
5.83
235.39
-229.56
-97.52%
Exceptional Items
0.00
-149.92
149.92
100.00%
Gross Profit (PBDT)
49.57
-159.26
208.83
131.13%
Depreciation
2.98
213.15
-210.17
-98.60%
Profit Before Tax
46.58
-372.41
418.99
112.51%
Tax
15.34
-92.54
107.88
116.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
31.24
-279.87
311.11
111.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
31.24
-279.87
311.11
111.16%
Share in Profit of Associates
-0.22
0.00
-0.22
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.02
-279.87
310.89
111.08%
Equity Capital
65.45
79.06
-13.61
-17.21%
Face Value
1.00
5.00
0.00
Reserves
292.03
1,675.57
-1,383.54
-82.57%
Earnings per share (EPS)
0.47
-17.70
18.17
102.66%
Diluted Earnings per share
0.45
-17.70
18.15
102.54%
Operating Profit Margin (Excl OI)
13.96%
4.69%
0.00
9.27%
Gross Profit Margin
16.06%
-3.77%
0.00
19.83%
PAT Margin
10.12%
-6.63%
0.00
16.75%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 308.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 178.75% vs 427.65% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 31.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2,463.64% vs -34.24% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,197.89% vs 78.49% in Mar 2025
Annual - Interest
Interest 5.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,140.43% vs 571.43% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.96%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
